Skip to content

The Application Value of Intermittent Electrocoagulation in Preventing Post-ESD Electrocoagulation Syndrome in Colorectal Surgery

The Application Value of Intermittent Electrocoagulation in Preventing Post-ESD Electrocoagulation Syndrome in Colorectal Surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500106435
Enrollment
Unknown
Registered
2025-07-23
Start date
2025-08-01
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastrointestinal Tumors

Interventions

Standard ESD:Electrocoagulation parameters: endocut Q (effect: 2, duration: 2, interval: 3) for mucosal incision
Submucosal incision: output 40W, effect 2 for submucosal dissection, output 40w, effect 4 for electrocoagulation. Direct electrocoagulation bleeding is used to incision, or thermal biopsy forceps are
Intermittent Electrocoagulation Group:For small blood vessels or small bleeding points, standard ESD is continuous electrocoagulation with electrosurgery until the vascular eschar stops bleeding, and

Sponsors

TheFirst Affiliated Hospital of Ningbo University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age >18 and =2 cm in maximum diameter meeting ESD treatment indications; 4.Single lesion resected in one ESD procedure; 5.Patient or legal guardian capable of understanding the study protocol, voluntarily participating, and providing written informed consent.

Exclusion criteria

Exclusion criteria: 1.Age 80 years; 2.Endoscopically diagnosed pedunculated polyps; 3.Circumferential lesions; 4.Patients with concurrent organic colorectal diseases; 5.Patients with familial adenomatous polyposis; 6.Pregnant or lactating women, or patients with severe emphysema, interstitial pneumonia, ischemic heart disease, or other conditions precluding safe anesthesia/surgery; 7.Patients with contraindications to ESD procedures; 8.Patients or guardians unable to comprehend the study requirements and objectives.

Design outcomes

Primary

MeasureTime frame
The rate of PECS;Intraoperative Perforation Rate;Postoperative Bleeding Rate;

Secondary

MeasureTime frame
The rate of Complete resection;The rate of R0;Intraoperative Massive Hemorrhage Rate;Postoperative Perforation Rate;

Countries

China

Contacts

Public ContactKefeng Hu

TheFirst Affiliated Hospital of Ningbo University

nbhkf@sina.cn+86 135 8650 5081

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026